Amahit, Hyde M.
HRN: 25-01-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2024
MUPIROCIN 2%, 15G (TUBE)
05/30/2024
06/05/2024
SKIN
Apply On Affected Area
OD
Sp LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes